Algorae Pharmaceuticals Limited (ASX:1AI)
Australia · Delayed Price · Currency is AUD 0.0080
-0.0010 (-11.11%)
Oct 9, 2026, 3:04 PM AEST
Algorae Pharmaceuticals Market Cap
Algorae Pharmaceuticals has a market cap or net worth of 16.22 million as of October 9, 2026. It is the 40,948th most valuable company in the world and the 1,173rd biggest in Australia. Its market cap has decreased by 12.61% in one year.
Market Cap
16.22M
Enterprise Value
12.28M
Revenue
n/a
Global Rank
Country Rank
#1,173 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since September 1, 2004, Algorae Pharmaceuticals's market cap has increased from 12.17M to 16.22M, an increase of 33.30%. That is a compound annual growth rate of 1.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 16.22M | -31.39% |
| Dec 31, 2025 | 23.64M | 133.52% |
| Dec 30, 2024 | 10.12M | -39.06% |
| Dec 29, 2023 | 16.61M | 7.70% |
| Dec 30, 2022 | 15.42M | 185.23% |
| Dec 30, 2021 | 5.41M | -32.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeuroScientific Biopharmaceuticals | 22.60M |
| Radiopharm Theranostics | 21.69M |
| Imugene | 20.08M |
| Proteomics International Laboratories | 19.84M |
| Noxopharm | 18.74M |
| Ceryvyn Therapeutics | 17.78M |
| Patrys | 17.47M |
| EZZ Life Science Holdings | 16.47M |